UNIVERSITEIT MAASTRICHT - (Coördinator)
Country:
Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
Full project pageOrganisations map overview
ACADEMISCH ZIEKENHUIS MAASTRICHT
Country:
CENTRE OSCAR LAMBRET
Country:
CLINICAL TRIAL CENTER MAASTRICHT
Country:
COMUNICARE SOLUTIONS
Country:
DANMARKS TEKNISKE UNIVERSITET
Country:
EUROPEAN CANCER PATIENT COALITION
Country:
EXOMNIS BIOTECH
Country:
Ghent University
Country:
HEALTH INNOVATION VENTURES BV
Country:
KATHOLIEKE UNIVERSITEIT LEUVEN
Country:
PHILOGEN SPA
Country:
PT THERAGNOSTIC BV
Country:
TECHNISCHE UNIVERSITAET DRESDEN
Country:
UNIVERSITA CATTOLICA DEL SACRO CUORE
Country:
UNIVERSITY COLLEGE LONDON
Country: